Ankylosing spondylitis, or AS, is a type of arthritis that affects the spine and the sacroiliac (SI) joints, where the spine meets the pelvis. It can also affect other joints and cause inflammation in the areas where tendons attach to bones. In severe cases, it can cause decreased range of motion in the spine, changes in posture, and chronic pain.
AS is an autoimmune condition, meaning it’s caused by the body’s own immune system reacting to healthy parts of the body. Experts used to think that AS was up to 9 times more common in men, but this is no longer the case. Men are more likely than women to show spine damage on X-rays, making them more likely to receive a diagnosis. With newer diagnostic criteria to account for this, experts believe men and women are affected equally.
It’s estimated that AS affects approximately 1% of adults in the U.S. But this may vary depending on location and the population studied.
The symptoms of AS depend on the affected areas of the body, which varies from person to person. Also, as with many autoimmune diseases, fatigue (extreme tiredness) is a problem for most people with AS. Symptoms usually begin before age 45.
Low back pain and stiffness are the most common symptoms of AS. Most people (at least 80%) experience back pain as their first symptom. Low back pain due to AS:
Starts gradually
Improves with exercise
Doesn’t improve with rest
Is worse at night
May travel down into the buttocks
Although the spine is most commonly affected, inflammation from AS can affect other joints. It can also cause inflammation where tendons attach to bones. This means AS can cause pain and stiffness in the following areas:
Hips
Knees
Ankles
Shoulders
Ribs/chest
People with AS often have other autoimmune disorders that affect other parts of the body:
Eyes: One in four people with AS have uveitis, which can cause eye redness, blurry vision, and sensitivity to bright light.
Abdomen: Inflammatory bowel disease, such as Crohn’s disease and ulcerative colitis, occurs in 6% to 14% of people with AS. This can cause abdominal pain and changes in bowel movements.
It’s unclear exactly what causes AS to start. Researchers believe that a complex combination of genetics and environmental factors causes AS. They’re investigating how risk factors (more on this below) might affect people who are susceptible.
There is a strong genetic component to AS, specifically involving a gene called HLA-B27. But only a small percentage of people with HLA-B27 get AS. And at least 10% of people with AS don’t have HLA-B27. So, even though there’s a connection, it’s not the only cause.
Risk factors aren’t causes but rather things that make you more likely to develop AS. Risk factors for AS include:
Below age 45
Genetics (HLA-B27)
Smoking
Gut microbiome changes
The HLA-B27 gene is more common in people with white Northern European backgrounds than in other ethnic groups. Researchers believe this gene somehow changes the gut microbiome (the trillions of bacteria in your gut). But more research is needed to understand this relationship.
A specific test for AS doesn’t exist. Because of this — and the fact that back and joint pain are common among adults — it can take years for people with AS to get a diagnosis.
Getting a diagnosis often requires a combination of your:
Symptoms
Medical history
Family medical history
Physical examination
Imaging tests (X-rays and/or MRI)
Bloodwork
X-rays often show signs of inflammation at the SI joints, or sacroiliitis. But not all people with AS have typical X-ray findings. Some people have what’s called a “non-radiographic” version of the disease. This means that there are no signs or changes seen on an X-ray, which is often how the condition gets diagnosed. Sometimes an MRI, which is more sensitive than an X-ray, can show signs of non-radiographic AS. But not always.
Blood tests that look for inflammation can also be helpful when autoimmune diseases are a possibility. These include erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). They alone can’t diagnose or rule out AS, but they can provide extra information.
Testing for HLA-B27 may also help. It’s not a diagnostic test. Rather, it’s a piece of the puzzle that can help to get a diagnosis. Remember: A positive HLA-B27 test doesn’t mean you have AS, and a negative test doesn’t mean you don’t.
Your primary care provider can order some or all of these tests. But you may also need to see a rheumatologist to help with diagnosis. This is someone who specializes in diagnosing and treating autoimmune conditions.
Symptoms of AS usually begin in early adulthood. It’s common to first experience low back pain and stiffness. When symptoms first start, there may not be significant changes on imaging tests, especially X-rays. MRIs are more sensitive at finding subtle changes, such as inflammation near the sacroiliac joints.
Without treatment, inflammation usually continues. The body responds by creating new bone in certain areas. This can lead to areas of bone growth where it shouldn’t be. It can happen in the rib cage and at places where tendons attach to bones.
This can also cause “bamboo spine,” when the spine looks like a stick of bamboo due to bone growth over the discs between the vertebrae. This causes pain and limited motion in the spine. There’s also an increased risk of vertebral fractures and nerve compression.
Other possible complications include:
Increased risk of cardiovascular disease
Amyloidosis (a condition of abnormal protein buildup in the organs)
People who receive a diagnosis of AS will likely be treated by a rheumatologist. The goals of AS treatment are to:
Reduce symptoms
Maintain motion in the spine and joints
Prevent permanent changes in posture
Help people live well and keep their independence
Medications are typically recommended first to help with pain and inflammation (more on this below).
Exercise also helps. For people with AS, it can reduce symptoms and inflammation. Research suggests that a physical therapy or home exercise program can help lessen pain and improve function.
If you are new to either exercise or AS, it’s a good idea to speak with your healthcare team before starting a new exercise program. Be sure to avoid spinal manipulation in order to avoid injury.
In some cases, AS worsens despite treatment with medication. If AS is severe and affects mobility or quality of life, surgery may be necessary. For example, hip replacement can improve motion and reduce pain related to hip arthritis. Spine surgery is usually reserved for people with severe posture changes. The decision to move forward with surgery should be made carefully and on an individual basis.
Medications that target inflammation or the immune system are often used to treat AS. Your rheumatologist can walk you through the possible side effects of each and help you decide which treatment is right for you.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are often very effective for treating AS. They’re recommended as first-choice treatment. Examples include:
Indomethacin (Tivorbex, Indocin)
Naproxen (Naprosyn, Anaprox DS)
Celecoxib (Celebrex)
Diclofenac (Arthrotec)
Research suggests that all NSAIDs are equally effective. Some people will need daily treatment, whereas others may take medication only when needed.
Biologic disease-modifying medications target specific molecules or cells in the inflammatory process. If treatment with NSAIDs doesn’t work well, treatment with a type of biologic called a tumor necrosis factor (TNF) inhibitor is recommended. Examples include:
Adalimumab (Humira)
Certolizumab pegol (Cimzia)
Etanercept (Enbrel)
Golimumab (Simponi)
Infliximab (Remicade)
If a TNF inhibitor does not work well enough, other biologic options include secukinumab (Cosentyx) or ixekizumab (Taltz).
No, there’s no cure. However, existing treatments can help relieve symptoms and prevent complications.
Ankylosing spondylitis is a type of arthritis. “Arthritis” simply means inflammation (“itis”) of joints (“arthro”). Different types of arthritis exist, such as osteoarthritis and rheumatoid arthritis.
Yes, it’s partly genetic. If someone in your family has AS, you’re more likely to get it. And if you have the gene HLA-B27, you’re more likely to get AS. But there are other factors — not just genes — that cause AS, which aren’t completely understood.
Flare-ups — episodes of worsening symptoms — are common in AS. They can be due to changes in medication, going too long between doses, stress, or infection. Sometimes, it’s not possible to identify a cause.
American College of Rheumatology. (n.d.). What is a rheumatologist?
Bedaiwi, M., et al. (2015). Fatigue in ankylosing spondylitis and non-radiographic axial spondyloarthritis: Analysis from a longitudinal observation cohort. The Journal of Rheumatology.
Bittar, M., et al. (2025). Axial spondyloarthritis. JAMA.
Braun, J., et al. (2023). Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis. RMD Open.
Dumain, T. (2019). What is sacroiliac (si) joint pain? The lower back pain you should know about. CreakyJoints.
Ermann, J. (n.d.). Examining flares in spondyloarthritis. Spondylitis Association of America.
Fragoulis, G. E., et al. (2019). Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment. World Journal of Gastroenterology.
Gravaldi, L. P., et al. (2022). Effectiveness of physiotherapy in patients with ankylosing spondylitis: A systematic review and meta-analysis. Healthcare.
Hwang, M. C., et al. (2022). Ankylosing spondylitis risk factors: A systematic literature. Clinical Rheumatology.
Knipe, H. (2025). Bamboo spine (ankylosing spondylitis). Radiopedia.
Kroon, F. P. B., et al. (2015). Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database of Systematic Reviews.
Rath, L. (2022). The link between hla-b27 and arthritis. Arthritis Foundation.
Richlin, C. et al. (2021). Axial spondyloarthritis: New advances in diagnosis and management. BMJ.
Stolwijk, C., et al. (2015). Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: A systematic review and meta-analysis. Annals of Rheumatic Diseases.
Stovall, R., et al. (2022). Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis. Nature Reviews Rheumatology.
Sveaas, S. H., et al. (2020). High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): A multicentre randomised trial of 100 patients. British Journal of Sports Medicine.
Ward, M. M., et al. (2016). American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care & Research.
Ward, M. M., et al. (2019). 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and non-radiographic axial spondyloarthritis. Arthritis & Rheumatology.
Zhao, S. S., et al. (2021). Diagnostic delay in axial spondyloarthritis: A systematic review and meta-analysis. Rheumatology.
Zhu, W., et al. (2019). Ankylosing spondylitis: Etiology, pathogenesis, and treatments. Bone Research.